Crossmark

Development of Optimized Sumatriptan–Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization

Crossref DOI link: https://doi.org/10.1208/s12249-022-02307-8

Published Online: 2022-06-02

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Javed, Sana

Hussain, Amjad

Shah, Pervaiz Akhtar

Raza, Syed Atif

Anwer, Ubaid Ullah

Shamim, Rahat

Rasool, Fatima

Hafiz, Muhammad Ahsan

Bukhari, Nadeem Irfan https://orcid.org/0000-0001-5710-9574
License Information

Text and Data Mining valid from 2022-06-02

Version of Record valid from 2022-06-02
More Information

Article History

Received: 16 February 2022

Accepted: 15 May 2022

First Online: 2 June 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below